Agilent Technologies’ New Member of GC Columns Ultra Inert Family Vital for Pesticide Analysis and Drugs of Abuse Testing

Agilent Technologies Inc.today announced the availability of the Agilent J&W DB-35ms Ultra Inert GC Column, the first mid-polarity column that specifically addresses the unique needs of drugs of abuse testing and pesticide analysis. The Agilent J&W DB-35ms Ultra Inert GC Column joins the existing apolar columns in the family, DB/HP-1ms and DB/HP-5ms.

With this new column, ultra inert performance is available for applications where mid-polar selectivity is needed for enhanced separations. Chemists can quantify components at a lower level, have broader linearity and optimize their separation by choosing the right selectivity to increase productivity.

“Inertness is becoming more and more important in the marketplace,” said Anne Jones, vice president of Agilent’s Chemistries Division. “The introduction of a mid-polar ultra inert column to our portfolio demonstrates Agilent’s commitment to continuing to provide innovative columns for the chromatography industry.”

The overall Agilent J&W Ultra Inert product family offers the most consistent column inertness with exceptionally low column bleed resulting in lower detection limits and more accurate data. Each column is tested with the most demanding test probe mixture in the industry and a performance summary sheet is shipped in each box. Chemists can have the utmost confidence that the column will meet demanding research requirements.

Agilent is the world’s leader in chromatography instrumentation, offering the widest selection of industry leading GC columns, sample preparation products and supplies. All are engineered or selected by experienced design teams, manufactured to demanding specifications and tested under a variety of strict conditions. Agilent’s entire GC portfolio ensures a lifetime of peak performance for the instrument and maximum productivity in the lab.

Information about Agilent is available on the Web at www.agilent.com.